Induction Toxicities Are More Frequent in Young Adults Compared to Children Treated on the Children's Oncology Group (COG) First Relapse B-Lymphoblastic Leukemia Clinical Trial AALL1331
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-112269
Abstract: Background COG AALL1331 randomizes first relapse B-lymphoblastic leukemia (B-ALL) patients ages 1-30 years (yrs) to standard chemotherapy +/- blinatumomab after a common Induction (Block 1) based on the mitoxantrone arm of UKR3 ALL (Parker et… read more here.
Keywords: first relapse; relapse; oncology; relapse lymphoblastic ... See more keywords